Skip to main content
Department of Pharmaceutics

Research

Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems

 

 

# Title Research Year
101 Self-Emulsifying Drug-Delivery Systems Modulate P-Glycoprotein Activity: Role of Excipients and Formulation Aspects 2018
102 Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals 2018
103 An Efficient PEGylated Gene Delivery System with Improved Targeting: Synergism between Octaarginine and a Fusogenic Peptide 2018
104 Role of Self-Emulsifying Drug Delivery Systems in Optimizing the Oral Delivery of Hydrophilic Macromolecules and Reducing Interindividual Variability 2018
105 Self-Emulsifying Drug-Delivery Systems Modulate P-Glycoprotein Activity: Role of Excipients and Formulation Aspects 2018
106 Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer : Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model 2018
107 Lipid-Coated Superparamagnetic Nanoparticles for Thermoresponsive Cancer Treatment 2018
108 Novel Targeted Lipid Nanoparticles Loaded with Synergistic Chemotherapy- Gene therapy Combination for Effective Treatment of Hepatocellular Carcinoma 2018
109 Role of Self-Emulsifying Drug Delivery Systems in Optimizing the Oral Delivery of Hydrophilic Macromolecules and Reducing Interindividual Variability 2018
110 Nanostructured Lipid Carriers for Improved Oral Delivery and Prolonged Antihyperlipidemic Effect of Simvastatin 2018